Free Trial

William Blair Investment Management LLC Has $24.40 Million Holdings in Cognex Corporation $CGNX

Cognex logo with Computer and Technology background

Key Points

  • William Blair Investment Management LLC reduced its holdings in Cognex Corporation by 86.3% during Q2, leaving it with approximately $24.40 million in shares after selling over 4.8 million shares.
  • Other hedge funds, including Nordea Investment Management AB which increased its position by 148.5%, collectively own 88.12% of Cognex's stock.
  • Cognex reported a 4.2% increase in revenue year-over-year, with $249.09 million during the last quarter and an EPS of $0.25, exceeding analyst expectations.
  • Five stocks we like better than Cognex.

William Blair Investment Management LLC lessened its holdings in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 86.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 769,087 shares of the scientific and technical instruments company's stock after selling 4,828,764 shares during the quarter. William Blair Investment Management LLC owned approximately 0.46% of Cognex worth $24,395,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Nordea Investment Management AB grew its position in Cognex by 148.5% during the second quarter. Nordea Investment Management AB now owns 7,075,772 shares of the scientific and technical instruments company's stock valued at $223,594,000 after purchasing an additional 4,228,729 shares in the last quarter. Mackenzie Financial Corp grew its holdings in shares of Cognex by 126.2% during the 1st quarter. Mackenzie Financial Corp now owns 4,609,802 shares of the scientific and technical instruments company's stock valued at $137,510,000 after acquiring an additional 2,571,457 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its stake in shares of Cognex by 32.0% in the first quarter. T. Rowe Price Investment Management Inc. now owns 6,082,319 shares of the scientific and technical instruments company's stock worth $181,436,000 after acquiring an additional 1,474,832 shares during the last quarter. ING Groep NV purchased a new stake in shares of Cognex during the first quarter worth $22,191,000. Finally, Price T Rowe Associates Inc. MD boosted its position in Cognex by 34.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 2,539,557 shares of the scientific and technical instruments company's stock valued at $75,756,000 after purchasing an additional 647,955 shares during the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Cognex

In related news, EVP Sheila Marie Dipalma sold 2,002 shares of the business's stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $45.00, for a total transaction of $90,090.00. Following the completion of the transaction, the executive vice president owned 8,582 shares of the company's stock, valued at approximately $386,190. The trade was a 18.92% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Cognex Stock Performance

NASDAQ CGNX opened at $46.04 on Monday. Cognex Corporation has a twelve month low of $22.67 and a twelve month high of $47.52. The stock has a market capitalization of $7.73 billion, a PE ratio of 64.85 and a beta of 1.50. The stock has a 50-day simple moving average of $44.62 and a 200 day simple moving average of $35.51.

Cognex (NASDAQ:CGNX - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.02. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The business had revenue of $249.09 million during the quarter, compared to analysts' expectations of $246.70 million. During the same quarter in the previous year, the firm earned $0.23 EPS. The firm's revenue was up 4.2% compared to the same quarter last year. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. As a group, equities research analysts forecast that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were given a dividend of $0.08 per share. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Thursday, August 14th. Cognex's payout ratio is currently 45.07%.

Analyst Ratings Changes

CGNX has been the topic of several research reports. The Goldman Sachs Group upped their target price on Cognex from $36.00 to $40.00 and gave the stock a "sell" rating in a research report on Tuesday, September 16th. Weiss Ratings restated a "hold (c)" rating on shares of Cognex in a report on Wednesday, October 8th. Citigroup reiterated a "neutral" rating and issued a $37.00 target price (up from $30.00) on shares of Cognex in a research note on Monday, July 14th. KeyCorp raised shares of Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 target price for the company in a research report on Friday, August 1st. Finally, Melius upgraded shares of Cognex from a "hold" rating to a "buy" rating and set a $60.00 price target on the stock in a report on Thursday, July 10th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $44.93.

Check Out Our Latest Analysis on CGNX

About Cognex

(Free Report)

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Articles

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.